First Time Loading...

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 3.92 USD 1.82% Market Closed
Updated: May 7, 2024

Harvard Bioscience Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Harvard Bioscience Inc
Cash from Financing Activities Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Harvard Bioscience Inc
NASDAQ:HBIO
Cash from Financing Activities
-$12.1m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Financing Activities
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash from Financing Activities
-$144m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
17%
West Pharmaceutical Services Inc
NYSE:WST
Cash from Financing Activities
-$659.6m
CAGR 3-Years
-56%
CAGR 5-Years
-42%
CAGR 10-Years
-34%
Agilent Technologies Inc
NYSE:A
Cash from Financing Activities
-$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
IQVIA Holdings Inc
NYSE:IQV
Cash from Financing Activities
-$382m
CAGR 3-Years
-21%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Harvard Bioscience Inc's Cash from Financing Activities?
Cash from Financing Activities
-12.1m USD

Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Cash from Financing Activities amounts to -12.1m USD.

What is Harvard Bioscience Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-15%

Over the last year, the Cash from Financing Activities growth was -327%. The average annual Cash from Financing Activities growth rates for Harvard Bioscience Inc have been -15% over the past three years .